{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:03:05Z","timestamp":1790316185506,"version":"4.1.0"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Basis for Supporting Innovative Drug Discovery and Life Science Research","award":["JP18am0101091"],"award-info":[{"award-number":["JP18am0101091"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.pharmthera.2019.05.018","type":"journal-article","created":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T22:13:41Z","timestamp":1559686421000},"page":"72-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Chronopharmacological strategies focused on chrono-drug discovery"],"prefix":"10.1016","volume":"202","author":[{"given":"Shigehiro","family":"Ohdo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Koyanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2019.05.018_bb0005","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.4049\/jimmunol.126.4.1360","article-title":"Studies on the bioperiodicity of the immune response. I. Circadian rhythms of human T, B, and K cell traffic in the peripheral blood","volume":"126","author":"Abo","year":"1981","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1124\/jpet.115.223891","article-title":"Dosing time-dependent changes in the analgesic effect of pregabalin on diabetic neuropathy in mice","volume":"354","author":"Akamine","year":"2015","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0015","doi-asserted-by":"crossref","first-page":"15643","DOI":"10.1073\/pnas.1003878107","article-title":"Noninvasive method for assessing the human circadian clock using hair follicle cells","volume":"107","author":"Akashi","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0020","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1523\/JNEUROSCI.19-03-01115.1999","article-title":"Inhibition of light- or glutamate-induced mPer1 expression represses the phase shifts into the mouse circadian locomotor and suprachiasmatic firing rhythms","volume":"19","author":"Akiyama","year":"1999","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1586\/eci.11.95","article-title":"Chronotherapy with modified-release prednisone in patients with rheumatoid arthritis","volume":"8","author":"Alten","year":"2012","journal-title":"Expert Review of Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0030","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000134","article-title":"Delayed-release prednisone improves fatigue and health-related quality of life: Findings from the CAPRA-2 double-blind randomised study in rheumatoid arthritis","volume":"1","author":"Alten","year":"2015","journal-title":"RMD Open"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0035","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3109\/03009742.2015.1038582","article-title":"Morning stiffness response with delayed-release prednisone after ineffective course of immediate-release prednisone","volume":"44","author":"Alten","year":"2015","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejps.2008.10.024","article-title":"Identifying mechanisms of chronotolerance and chronoefficacy for the anticancer drugs 5-fluorouracil and oxaliplatin by computational modeling","volume":"36","author":"Altinok","year":"2009","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0045","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.ph.25.030163.003053","article-title":"Comparative physiology: Diurnal rhythms","volume":"25","author":"Aschoff","year":"1963","journal-title":"Annual Review of Physiology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0050","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1081\/CBI-120014105","article-title":"Case study of circadian rhythm sleep disorder following haloperidol treatment: Reversal by risperidone and melatonin","volume":"19","author":"Ayalon","year":"2002","journal-title":"Chronobiology International"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0055","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1126\/science.289.5488.2344","article-title":"Resetting of circadian time in peripheral tissues by glucocorticoid signaling","volume":"289","author":"Balsalobre","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0060","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0092-8674(95)90201-5","article-title":"Steroid hormone receptors: Many actors in search of a plot","volume":"83","author":"Beato","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0065","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/bmj.286.6372.1171","article-title":"Diurnal variation of lymphocyte subsets identified by monoclonal antibodies","volume":"286","author":"Bertouch","year":"1983","journal-title":"British Medical Journal (Clinical Research Ed.)"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0070","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/cdd.1985.2.313","article-title":"Administration of interferon at night may increase its therapeutic index","volume":"2","author":"Bocci","year":"1985","journal-title":"Cancer Drug Delivery"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0075","series-title":"Distribution catabolism and pharmacokinetics of interferons","first-page":"47","author":"Bocci","year":"1985"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0080","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0149-7634(80)90010-X","article-title":"Food availability and daily biological rhythms","volume":"4","author":"Boulos","year":"1980","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0085","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1210\/jcem-29-8-1074","article-title":"Once-a-day neurally stimulated and basal ACTH secretion phases in man and their response to corticoid inhibition","volume":"29","author":"Ceresa","year":"1969","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0090","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0896-6273(01)00230-6","article-title":"The circadian clocks of mice and men","volume":"29","author":"Chang","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0095","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2125.1989.tb05353.x","article-title":"Bayesian derived predictions for twice daily theophylline under outpatient conditions and an assessment of optimal sampling times","volume":"27","author":"Chrystyn","year":"1989","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0100","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.2.6132.253","article-title":"Circadian variation in an immune response in man","volume":"2","author":"Cove-Smith","year":"1978","journal-title":"British Medical Journal"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0105","first-page":"19","article-title":"Circadian rhythm sleep disorders (CRSD) in psychiatry\u2014A review","volume":"39","author":"Dagan","year":"2002","journal-title":"The Israel Journal of Psychiatry and Related Sciences"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/07420529808998682","article-title":"Evaluating the role of melatonin in the long-term treatment of delayed sleep phase syndrome (DSPS)","volume":"15","author":"Dagan","year":"1998","journal-title":"Chronobiology International"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0115","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1101\/gad.183500","article-title":"Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus","volume":"14","author":"Damiola","year":"2000","journal-title":"Genes & Development"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.mrfmmm.2003.11.016","article-title":"Changes in expression level of genes as a function of time of day in the liver of rats","volume":"549","author":"Desai","year":"2004","journal-title":"Mutation Research"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0125","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0163-7258(96)00092-7","article-title":"Circadian rhythms and the pharmacology of affective illness","volume":"71","author":"Duncan","year":"1996","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0168-8278(96)80184-X","article-title":"A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon","volume":"24","author":"Fattovich","year":"1996","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0140","series-title":"Electronic orange book","author":"FDA","year":"2003"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0145","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mrgentox.2009.10.002","article-title":"Circadian disruption accelerates liver carcinogenesis in mice","volume":"680","author":"Filipski","year":"2009","journal-title":"Mutation Research"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cmet.2006.04.015","article-title":"The circadian PAR-domain basic leucine zipper transcription factors DBP, TEF, and HLF modulate basal and inducible xenobiotic detoxification","volume":"4","author":"Gachon","year":"2006","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0155","first-page":"5","article-title":"A cell-surface molecule involved in organ-specific homing of lymphocytes","volume":"177","author":"Gallatin","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0160","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.4049\/jimmunol.127.4.1569","article-title":"Interferon induces peripheral lymphadenopathy in mice","volume":"127","author":"Gresser","year":"1981","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0165","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1146\/annurev.ph.31.030169.003331","article-title":"Chronobiology","volume":"31","author":"Halberg","year":"1969","journal-title":"Annual Review of Physiology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0170","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1074\/jbc.M115.696930","article-title":"Alterations of hepatic metabolism in chronic kidney disease via D-box-binding protein aggravate the renal dysfunction","volume":"291","author":"Hamamura","year":"2016","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0175","doi-asserted-by":"crossref","first-page":"17224","DOI":"10.1074\/jbc.M111.333377","article-title":"Intestinal expression of mouse Abcg2\/breast cancer resistance protein (BCRP) gene is under control of circadian clock-activating transcription factor-4 pathway","volume":"287","author":"Hamdan","year":"2012","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0180","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/aja.1001680406","article-title":"Chronobiology in hematology and immunology","volume":"168","author":"Haus","year":"1983","journal-title":"The American Journal of Anatomy"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0185","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.3109\/07420528.2010.515324","article-title":"Proxisome proliferator-activated receptor-alpha mediates high-fat, diet-enhanced daily oscillation of plasminogen activator inhibitor-1 activity in mice","volume":"27","author":"Hayashida","year":"2010","journal-title":"Chronobiology International"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0190","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1017\/S1092852900008051","article-title":"Circadian rhythm sleep disorders as a possible side effect of fluvoxamine","volume":"6","author":"Hermesh","year":"2001","journal-title":"CNS Spectrums"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0195","first-page":"E948","article-title":"Roles of paraventricular catecholamines in feeding-associated corticosterone rhythm in rats","volume":"262","author":"Honma","year":"1992","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0200","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1124\/jpet.110.165597","article-title":"Glucocorticoid-dependent expression of O(6)-methylguanine-DNA methyltransferase gene modulates dacarbazine-induced hepatotoxicity in mice","volume":"333","author":"Horiguchi","year":"2010","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0205","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1158\/0008-5472.CAN-12-2492","article-title":"Rhythmic control of the ARF-MDM2 pathway by ATF4 underlies circadian accumulation of p53 in malignant cells","volume":"73","author":"Horiguchi","year":"2013","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0210","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1523\/JNEUROSCI.20-15-05867.2000","article-title":"Nonphotic entrainment by 5-HT1A\/7 receptor agonists accompanied by reduced Per1 and Per2 mRNA levels in the suprachiasmatic nuclei","volume":"20","author":"Horikawa","year":"2000","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1126\/science.3883493","article-title":"Circadian timing of cancer chemotherapy","volume":"228","author":"Hrushesky","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-2478(97)00091-6","article-title":"Type I interferons enhance production of IFN-gamma by NK cells","volume":"59","author":"Hunter","year":"1997","journal-title":"Immunology Letters"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0225","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1124\/mol.112.083535","article-title":"Molecular mechanism regulating 24-hour rhythm of dopamine D3 receptor expression in mouse ventral striatum","volume":"83","author":"Ikeda","year":"2013","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0230","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1158\/0008-5472.CAN-08-4747","article-title":"Circadian rhythm in rest and activity: A biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer","volume":"69","author":"Innominato","year":"2009","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0235","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1124\/mol.114.096735","article-title":"Circadian modulation in the intestinal absorption of P-glycoprotein substrates in monkeys","volume":"88","author":"Iwasaki","year":"2015","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0240","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0168-8278(05)80402-7","article-title":"Suicide associated with alfa-interferon therapy for chronic viral hepatitis","volume":"21","author":"Janssen","year":"1994","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0245","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80959-9","article-title":"A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock","volume":"96","author":"Jin","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0250","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/12502","article-title":"Familial advanced sleep-phase syndrome: A short-period circadian rhythm variant in humans","volume":"5","author":"Jones","year":"1999","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0255","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1523\/JNEUROSCI.16-17-05555.1996","article-title":"A diurnal rhythm of stimulatory input to the hypothalamo-pituitary-adrenal system as revealed by timed intrahypothalamic administration of the vasopressin V1 antagonist","volume":"16","author":"Kalsbeek","year":"1996","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0260","doi-asserted-by":"crossref","first-page":"21397","DOI":"10.1074\/jbc.M117.791285","article-title":"Periodic variation in bile acids controls circadian changes in uric acid via regulation of xanthine oxidase by the orphan nuclear receptor PPARalpha","volume":"292","author":"Kanemitsu","year":"2017","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0265","doi-asserted-by":"crossref","first-page":"15036","DOI":"10.1073\/pnas.1207768109","article-title":"Human blood metabolite timetable indicates internal body time","volume":"109","author":"Kasukawa","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0270","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.bcp.2009.06.013","article-title":"Clock gene mutation modulates the cellular sensitivity to genotoxic stress through altering the expression of N-methylpurine DNA glycosylase gene","volume":"78","author":"Kim","year":"2009","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0275","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2217\/pgs.09.38","article-title":"Systems biology in pharmacogenomic research: The way to personalized prescribing?","volume":"10","author":"Koster","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0280","first-page":"7277","article-title":"A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells","volume":"63","author":"Koyanagi","year":"2003","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0285","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13102","article-title":"Glucocorticoid regulation of ATP release from spinal astrocytes underlies diurnal exacerbation of neuropathic mechanical allodynia","volume":"7","author":"Koyanagi","year":"2016","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0290","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1210\/endo-106-3-649","article-title":"Ventromedial hypothalamic lesions abolish food-shifted circadian adrenal and temperature rhythmicity","volume":"106","author":"Krieger","year":"1980","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0295","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1126\/science.877566","article-title":"Suprachiasmatic nuclear lesions do not abolish food-shifted circadian adrenal and temperature rhythmicity","volume":"197","author":"Krieger","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0300","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0092-8674(00)81014-4","article-title":"mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop","volume":"98","author":"Kume","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0305","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1744-8069-6-83","article-title":"Molecular basis for the dosing time-dependency of anti-allodynic effects of gabapentin in a mouse model of neuropathic pain","volume":"6","author":"Kusunose","year":"2010","journal-title":"Molecular Pain"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0310","doi-asserted-by":"crossref","first-page":"6488","DOI":"10.1128\/MCB.19.10.6488","article-title":"Circadian expression of the steroid 15 alpha-hydroxylase (Cyp2a4) and coumarin 7-hydroxylase (Cyp2a5) genes in mouse liver is regulated by the PAR leucine zipper transcription factor DBP","volume":"19","author":"Lavery","year":"1999","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0315","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1470-2045(00)00326-0","article-title":"Circadian chronotherapy for human cancers","volume":"2","author":"Levi","year":"2001","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0320","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(97)03358-8","article-title":"Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy","volume":"350","author":"Levi","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0325","series-title":"Melatonin after four decades. An assessment of its potentia","first-page":"425","article-title":"Melatonin as a marker and phase-resetter of circadian rhythms in humans","author":"Lewy","year":"1999"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0330","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S0140-6736(99)00403-1","article-title":"Severe loss of vision during adjuvant interferon alfa-2b treatment for malignant melanoma","volume":"353","author":"Lohmann","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0335","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/00001756-199804200-00018","article-title":"Expression of an oscillating interferon-gamma receptor in the suprachiasmatic nuclei","volume":"9","author":"Lundkvist","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0340","doi-asserted-by":"crossref","first-page":"36847","DOI":"10.1074\/jbc.C000629200","article-title":"CLIF, a novel cycle-like factor, regulates the circadian oscillation of plasminogen activator inhibitor-1 gene expression","volume":"275","author":"Maemura","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0345","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ebiom.2016.10.008","article-title":"Inhibition of G0\/G1 switch 2 ameliorates renal inflammation in chronic kidney disease","volume":"13","author":"Matsunaga","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0350","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/hep.22304","article-title":"The molecular mechanism regulating 24-hour rhythm of CYP2E1 expression in the mouse liver","volume":"48","author":"Matsunaga","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0355","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1124\/mol.111.076406","article-title":"Time-dependent interaction between differentiated embryo chondrocyte-2 and CCAAT\/enhancer-binding protein alpha underlies the circadian expression of CYP2D6 in serum-shocked HepG2 cells","volume":"81","author":"Matsunaga","year":"2012","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0360","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/jid.2014.13","article-title":"24-hour rhythm of aquaporin-3 function in the epidermis is regulated by molecular clocks","volume":"134","author":"Matsunaga","year":"2014","journal-title":"The Journal of Investigative Dermatology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0365","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1158\/0008-5472.CAN-17-4034","article-title":"Optimized dosing schedule based on circadian dynamics of mouse breast cancer stem cells improves the antitumor effects of aldehyde dehydrogenase inhibitor","volume":"78","author":"Matsunaga","year":"2018","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0370","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1126\/science.1086271","article-title":"Control mechanism of the circadian clock for timing of cell division in vivo","volume":"302","author":"Matsuo","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0375","doi-asserted-by":"crossref","first-page":"9890","DOI":"10.1073\/pnas.0900617106","article-title":"Measurement of internal body time by blood metabolomics","volume":"106","author":"Minami","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0380","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0006-8993(72)90054-6","article-title":"Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat","volume":"42","author":"Moore","year":"1972","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0385","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1053\/j.gastro.2008.07.073","article-title":"Circadian clock-controlled intestinal expression of the multidrug-resistance gene mdr1a in mice","volume":"135","author":"Murakami","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0390","doi-asserted-by":"crossref","first-page":"8328","DOI":"10.1158\/0008-5472.CAN-04-2122","article-title":"24-hour oscillation of mouse methionine aminopeptidase2, a regulator of tumor progression, is regulated by clock gene proteins","volume":"64","author":"Nakagawa","year":"2004","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0395","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.bcp.2006.08.002","article-title":"Basis for dosing time-dependent change in the anti-tumor effect of imatinib in mice","volume":"72","author":"Nakagawa","year":"2006","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0400","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3177\/jnsv.38.117","article-title":"Effects of cyclic and continuous total enteral nutrition on 24-h rhythms of body temperature and urinary excretions","volume":"38","author":"Nishimura","year":"1992","journal-title":"Journal of Nutritional Science and Vitaminology (Tokyo)"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0405","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1124\/mol.113.089805","article-title":"Renal circadian clock regulates the dosing-time dependency of cisplatin-induced nephrotoxicity in mice","volume":"85","author":"Oda","year":"2014","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0410","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.addr.2010.01.006","article-title":"Chronotherapeutic strategy: Rhythm monitoring, manipulation and disruption","volume":"62","author":"Ohdo","year":"2010","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0415","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.addr.2010.04.005","article-title":"Chronopharmacological strategies: Intra- and inter-individual variability of molecular clock","volume":"62","author":"Ohdo","year":"2010","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0420","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/85507","article-title":"Changing the dosing schedule minimizes the disruptive effects of interferon on clock function","volume":"7","author":"Ohdo","year":"2001","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0425","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0022-3565(24)37141-1","article-title":"Cell cycle-dependent chronotoxicity of irinotecan hydrochloride in mice","volume":"283","author":"Ohdo","year":"1997","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0430","first-page":"747","article-title":"An influencing factor to predict plasma valproate concentrations: Circadian stage-dependent kinetics","volume":"21","author":"Ohdo","year":"1990","journal-title":"Japanese Journal of Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0435","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/07420529109063917","article-title":"Chronopharmacokinetics of valproic acid following constant-rate administration in mice","volume":"8","author":"Ohdo","year":"1991","journal-title":"Chronobiology International"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0440","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0022-3565(25)20109-4","article-title":"Influence of feeding schedule on the chronopharmacological aspects of sodium valproate in mice","volume":"278","author":"Ohdo","year":"1996","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0445","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0022-3565(24)39097-4","article-title":"Basis for dosing time-dependent changes in the antiviral activity of interferon-alpha in mice","volume":"294","author":"Ohdo","year":"2000","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0450","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1124\/mol.110.064402","article-title":"Bezafibrate induces plasminogen activator inhibitor-1 gene expression in a CLOCK-dependent circadian manner","volume":"78","author":"Oishi","year":"2010","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0455","doi-asserted-by":"crossref","first-page":"25296","DOI":"10.1074\/jbc.M114.577023","article-title":"Bile acid-regulated peroxisome proliferator-activated receptor-alpha (PPARalpha) activity underlies circadian expression of intestinal peptide absorption transporter PepT1\/Slc15a1","volume":"289","author":"Okamura","year":"2014","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0460","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.1074\/jbc.M115.713412","article-title":"Circadian clock in a mouse colon tumor regulates intracellular iron levels to promote tumor progression","volume":"291","author":"Okazaki","year":"2016","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0465","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.1158\/0008-5472.CAN-10-0184","article-title":"Circadian rhythm of transferrin receptor 1 gene expression controlled by c-Myc in colon cancer-bearing mice","volume":"70","author":"Okazaki","year":"2010","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0470","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1158\/0008-5472.CAN-12-3241","article-title":"Circadian regulation of mTOR by the ubiquitin pathway in renal cell carcinoma","volume":"74","author":"Okazaki","year":"2014","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0475","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/archopht.1995.01100080093034","article-title":"Anterior ischemic optic neuropathy secondary to interferon alfa","volume":"113","author":"Purvin","year":"1995","journal-title":"Archives of Ophthalmology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0480","series-title":"Chronopharmacology. Cellular and biochemical interactions","first-page":"137","article-title":"Chronopharmacology of corticosteroids and ACTH","author":"Reinberg","year":"1989"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0485","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev.pa.11.040171.002323","article-title":"Circadian chronopharmacology","volume":"11","author":"Reinberg","year":"1971","journal-title":"Annual Review of Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0490","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/07420528709083530","article-title":"Comparison of once-daily evening versus morning sustained-release theophylline dosing for nocturnal asthma","volume":"4","author":"Reinberg","year":"1987","journal-title":"Chronobiology International"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0495","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/02770908809071368","article-title":"Chronobiology and asthma. III. Timing corticotherapy to biological rhythms to optimize treatment goals","volume":"25","author":"Reinberg","year":"1988","journal-title":"The Journal of Asthma"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0500","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1101\/gad.14.6.679","article-title":"CLOCK, an essential pacemaker component, controls expression of the circadian transcription factor DBP","volume":"14","author":"Ripperger","year":"2000","journal-title":"Genes & Development"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0505","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1136\/bmj.286.6380.1773","article-title":"Circadian variation of lymphocyte subpopulations: A study with monoclonal antibodies","volume":"286","author":"Ritchie","year":"1983","journal-title":"British Medical Journal (Clinical Research Ed.)"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0510","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3177\/jnsv.35.639","article-title":"Modifications of circadian cortisol rhythm by cyclic and continuous total enteral nutrition","volume":"35","author":"Saito","year":"1989","journal-title":"Journal of Nutritional Science and Vitaminology (Tokyo)"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0515","doi-asserted-by":"crossref","first-page":"27039","DOI":"10.1074\/jbc.273.42.27039","article-title":"Multitissue circadian expression of rat period homolog (rPer2) mRNA is governed by the mammalian circadian clock, the suprachiasmatic nucleus in the brain","volume":"273","author":"Sakamoto","year":"1998","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0520","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/bmj.282.6273.1345","article-title":"Toxicity of interferon","volume":"282","author":"Scott","year":"1981","journal-title":"British Medical Journal (Clinical Research Ed.)"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0525","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1128\/AAC.23.4.589","article-title":"Effects of cloned interferon alpha 2 in normal volunteers: Febrile reactions and changes in circulating corticosteroids and trace metals","volume":"23","author":"Scott","year":"1983","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0530","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0092-8674(00)80494-8","article-title":"Light-induced resetting of a mammalian circadian clock is associated with rapid induction of the mPer1 transcript","volume":"91","author":"Shigeyoshi","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0535","doi-asserted-by":"crossref","first-page":"12071","DOI":"10.1073\/pnas.0502383102","article-title":"Brain and muscle Arnt-like protein-1 (BMAL1), a component of the molecular clock, regulates adipogenesis","volume":"102","author":"Shimba","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0540","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1248\/bpb.31.95","article-title":"Chronopharmacologic cancer treatment with an angiogenic vessel-targeted liposomal drug","volume":"31","author":"Shimizu","year":"2008","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0545","first-page":"32","article-title":"Formulation technologies for chrono therapy of epilepsy: A review","volume":"3","author":"Silas","year":"2017","journal-title":"Asian Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0550","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/382810a0","article-title":"A diffusible coupling signal from the transplanted suprachiasmatic nucleus controlling circadian locomotor rhythms","volume":"382","author":"Silver","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0555","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2217\/pgs.09.154","article-title":"Clinical pharmacology and pharmacogenetics in a genomics era: The DMET platform","volume":"11","author":"Sissung","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0560","series-title":"Physiology and pharmacology of biological rhythms","first-page":"205","article-title":"Progress in the chronotherapy of nocturnal asthma","author":"Smolensky","year":"1997"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0565","first-page":"10","article-title":"Chronotherapeutics","volume":"4","author":"Smolensky","year":"1997","journal-title":"Pharmaceutical News"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0570","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/FPC.0b013e3282f12a61","article-title":"Molecular basis for rhythmic expression of CYP3A4 in serum-shocked HepG2 cells","volume":"17","author":"Takiguchi","year":"2007","journal-title":"Pharmacogenetics and Genomics"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0575","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.tox.2011.09.007","article-title":"Aryl hydrocarbon receptor-mediated Cyp1a1 expression is modulated in a CLOCK-dependent circadian manner","volume":"290","author":"Tanimura","year":"2011","journal-title":"Toxicology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0580","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/39086","article-title":"Circadian oscillation of a mammalian homologue of the Drosophila period gene","volume":"389","author":"Tei","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0585","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.bcp.2008.01.011","article-title":"Modulatory effects of 5-fluorouracil on the rhythmic expression of circadian clock genes: A possible mechanism of chemotherapy-induced circadian rhythm disturbances","volume":"75","author":"Terazono","year":"2008","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0590","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1126\/science.1057499","article-title":"An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome","volume":"291","author":"Toh","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0595","doi-asserted-by":"crossref","first-page":"9072","DOI":"10.1038\/s41598-018-27280-w","article-title":"Circadian clock component PERIOD2 regulates diurnal expression of Na(+)\/H(+) exchanger regulatory factor-1 and its scaffolding function","volume":"8","author":"Tsurudome","year":"2018","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0605","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1053\/jhep.2002.32873","article-title":"Liver has rhythm","volume":"35","author":"Turek","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0610","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF00316473","article-title":"The pharmacokinetics of the beta 2-adrenoceptor agonist, tulobuterol, given transdermally and by inhalation","volume":"44","author":"Uematsu","year":"1993","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0615","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/15973","article-title":"Suprachiasmatic nucleus: a central autonomic clock","volume":"2","author":"Ueyama","year":"1999","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0620","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/mol.112.079079","article-title":"Role of activating transcription factor-4 in 24-hour rhythm of serotonin transporter expression in the mouse midbrain","volume":"82","author":"Ushijima","year":"2012","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0625","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/mol.114.094979","article-title":"Modulation of peroxisome proliferator-activated receptor-alpha activity by bile acids causes circadian changes in the intestinal expression of Octn1\/Slc22a4 in mice","volume":"87","author":"Wada","year":"2015","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0630","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-1781(97)00117-0","article-title":"A schizophrenic patient with an arrhythmic circadian rest-activity cycle","volume":"73","author":"Wirz-Justice","year":"1997","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0635","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00002093-200010000-00005","article-title":"Haloperidol disrupts, clozapine reinstates the circadian rest-activity cycle in a patient with early-onset Alzheimer disease","volume":"14","author":"Wirz-Justice","year":"2000","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0640","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1460-9568.1995.tb00334.x","article-title":"Block of c-Fos and JunB expression by antisense oligonucleotides inhibits light-induced phase shifts of the mammalian circadian clock","volume":"7","author":"Wollnik","year":"1995","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0645","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1128\/MCB.20.13.4773-4781.2000","article-title":"Role of DBP in the circadian oscillatory mechanism","volume":"20","author":"Yamaguchi","year":"2000","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0650","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/(SICI)1097-4547(20000115)59:2<291::AID-JNR16>3.0.CO;2-O","article-title":"Distribution and circadian expression of dbp in SCN and extra-SCN areas in the mouse brain","volume":"59","author":"Yan","year":"2000","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0655","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2004.05.015","article-title":"Chronopharmaceutics: Gimmick or clinically relevant approach to drug delivery?","volume":"98","author":"Youan","year":"2004","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb1005","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.addr.2010.04.010","article-title":"Chronopharmaceutical drug delivery systems: Hurdles, hype or hope?","volume":"62","author":"Youan","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0660","doi-asserted-by":"crossref","first-page":"738","DOI":"10.2174\/138920008786049302","article-title":"Clinical pharmacogenetics and potential application in personalized medicine","volume":"9","author":"Zhou","year":"2008","journal-title":"Current Drug Metabolism"},{"key":"10.1016\/j.pharmthera.2019.05.018_bb0665","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0896-6273(00)80492-4","article-title":"Three period homologs in mammals: Differential light responses in the suprachiasmatic circadian clock and oscillating transcripts outside of brain","volume":"20","author":"Zylka","year":"1998","journal-title":"Neuron"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725819301019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725819301019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:00:50Z","timestamp":1759010450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725819301019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":132,"alternative-id":["S0163725819301019"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2019.05.018","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronopharmacological strategies focused on chrono-drug discovery","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2019.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}